Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Japanese Journal of Radiology
Published in: Japanese Journal of Radiology 4/2020

Open Access 01-04-2020 | Propranolol | Special Report

Japanese clinical practice guidelines for vascular anomalies 2017

Authors: Hidefumi Mimura, Sadanori Akita, Akihiro Fujino, Masatoshi Jinnin, Mine Ozaki, Keigo Osuga, Hiroki Nakaoka, Eiichi Morii, Akira Kuramochi, Yoko Aoki, Yasunori Arai, Noriko Aramaki, Masanori Inoue, Yuki Iwashina, Tadashi Iwanaka, Shigeru Ueno, Akihiro Umezawa, Michio Ozeki, Junko Ochi, Yoshiaki Kinoshita, Masakazu Kurita, Shien Seike, Nobuyuki Takakura, Masataka Takahashi, Takao Tachibana, Kumiko Chuman, Shuji Nagata, Mitsunaga Narushima, Yasunari Niimi, Shunsuke Nosaka, Taiki Nozaki, Kazuki Hashimoto, Ayato Hayashi, Satoshi Hirakawa, Atsuko Fujikawa, Yumiko Hori, Kentaro Matsuoka, Hideki Mori, Yuki Yamamoto, Shunsuke Yuzuriha, Naoaki Rikihisa, Shoji Watanabe, Shinichi Watanabe, Tatsuo Kuroda, Shunsuke Sugawara, Kosuke Ishikawa, Satoru Sasaki

Published in: Japanese Journal of Radiology | Issue 4/2020

Login to get access

Abstract

The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence-based medicine (EBM) techniques and aimed at improvement of the outcomes. Clinical questions (CQs) were decided based on the important clinical issues. For document retrieval, key words for literature searches were set for each CQ and literature published from 1980 to the end of September 2014 was searched in Pubmed, Cochrane Library, and Japana Centra Revuo Medicina (JCRM). The strengths of evidence and recommendations acquired by systematic reviews were determined following the Medical Information Network Distribution System (MINDS) technique. A total of 33 CQs were used to compile recommendations and the subjects included efficacy of resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy, and other conservative treatment, differences in appropriate treatment due to the location of lesions and among symptoms, appropriate timing of treatment and tests, and pathological diagnosis deciding the diagnosis. Thus, the Japanese Clinical Practice Guidelines for Vascular Anomalies 2017 have been prepared as the evidence-based guidelines for the management of vascular anomalies.
Literature
1.
2.
Wassef M, Blei F, Adams D, Alomari A, Baselga E, Berenstein A, et al. Vascular anomalies classification: recommendations from the international society for the study of vascular anomalies. Pediatrics. 2015;136:e203–14.PubMedCrossRef
3.
4.
5.
Morizane T, Yoshida M (eds). Minds manual for guideline development Ver. 1.0. Tokyo: Japan Council for Quality Health Care. Accessed 31 Mar 2014 (Japanese).
6.
7.
Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64:401–6.PubMedCrossRef
8.
Andrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck-Ytter Y, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol. 2013;66:719–25.PubMedCrossRef
9.
Liu AS, Mulliken JB, Zurakowski D, Fishman SJ, Greene AK. Extracranial arteriovenous malformations: natural progression and recurrence after treatment. Plast Reconstr Surg. 2010;125:1185–94.PubMedCrossRef
10.
Kohout MP, Hansen M, Pribaz JJ, Mulliken JB. Arteriovenous malformations of the head and neck: natural history and management. Plast Reconstr Surg. 1998;102:643–54.PubMedCrossRef
11.
Richter GT, Suen J, North PE, James CA, Waner M, Buckmiller LM. Arteriovenous malformations of the tongue: a spectrum of disease. Laryngoscope. 2007;117:328–35.PubMedCrossRef
12.
Hyun D, Do YS, Park KB, Kim DI, Kim YW, Park HS, et al. Ethanol embolotherapy of foot arteriovenous malformations. J Vasc Surg. 2013;58:1619–26.PubMedCrossRef
13.
Park KB, Do YS, Kim DI, Kim YW, Shin BS, Park HS, et al. Predictive factors for response of peripheral arteriovenous malformations to embolization therapy: analysis of clinical data and imaging findings. J Vasc Interv Radiol. 2012;23:1478–86.PubMedCrossRef
14.
Wu JK, Bisdorff A, Gelbert F, Enjolras O, Burrows PE, Mulliken JB. Auricular arteriovenous malformation: evaluation, management, and outcome. Plast Reconstr Surg. 2005;115:985–95.PubMedCrossRef
15.
DesPrez JD, Kiehn CL, Vlastou C, Bonstelle C. Congenital arteriovenous malformation of the head and neck. Am J Surg. 1978;136:424–9.PubMedCrossRef
16.
Dompmartin A, Labbé D, Barrellier MT, Théron J. Use of a regulating flap in the treatment of a large arteriovenous malformation of the scalp. Br J Plast Surg. 1998;51:561–3.PubMedCrossRef
17.
Yamamoto Y, Ohura T, Minakawa H, Sugihara T, Yoshida T, Nohira K, et al. Experience with arteriovenous malformations treated with flap coverage. Plast Reconstr Surg. 1994;94:476–82.PubMedCrossRef
18.
Hartzell LD, Stack BC Jr, Yuen J, Vural E, Suen JY. Free tissue reconstruction following excision of head and neck arteriovenous malformations. Arch Facial Plast Surg. 2009;11:171–7.PubMedCrossRef
19.
Visser A, FitzJohn T, Tan ST. Surgical management of arteriovenous malformation. J Plast Reconstr Aesthet Surg. 2011;64:283–91.PubMedCrossRef
20.
Hong JP, Choi JW, Chang H, Lee TJ. Reconstruction of the face after resection of arteriovenous malformations using anterolateral thigh perforator flap. J Craniofac Surg. 2005;16:851–5.PubMedCrossRef
21.
Koshima I, Takahashi Y, Namba Y, Inagawa K, Oka H, Moriguchi T, et al. Treatment for arteriovenous malformation. Keisei Geka. 2001;44:665–73 (Japanese).
22.
Toh S, Tsubo K, Arai H, Harata S. Vascularized free flaps for reconstruction after resection of congenital arteriovenous malformations of the hand. J Reconstr Microsurg. 2000;16:511–7.PubMedCrossRef
23.
Yokoo K, Nishihori K, Kono A, Ishiguchi T, Ohta T. Surgical treatment of arteriovenous malformations in the head and neck combined with antecedent embolization. Keisei Geka. 2009;52:1201–8 (Japanese).
24.
Koshima I, Nanba Y, Tsutsui T, Takahashi Y, Watanabe A, Ishii R. Free perforator flap for the treatment of defects after resection of huge arteriovenous malformations in the head and neck regions. Ann Plast Surg. 2003;51:194–9.PubMedCrossRef
25.
Kajitani N, Ikuta Y, Ishida O, Mochizuki Y, Kimori K. Surgical treatment of arteriovenous fistula of the hand. Nihon Te No Geka Gakkai Zasshi. 1999;15:758–61 (Japanese).
26.
Minami A, Kato H, Hirachi K. Complete removal plus dorsalis pedis flap for arteriovenous malformation in the hypothenar region. J Reconstr Microsurg. 1998;14:439–43.PubMedCrossRef
27.
Koshima I, Soeda S, Murashita T. Extended wrap-around flap for reconstruction of the finger with recurrent arteriovenous malformation. Plast Reconstr Surg. 1993;91:1140–4.PubMedCrossRef
28.
Wojcicki P, Wojcicka K. The treatment of extensive arteriovenous malformations in the head. Pol Przegl Chir. 2013;85:83–9.PubMedCrossRef
29.
Ermer MA, Gutwald R, Schumacher M, Schmelzeisen R, Taschner C. Use of the radial forearm artery for secondary embolization of an extensive life-threatening arteriovenous malformation of the mid-face and anterior skull base—a case report. J Craniomaxillofac Surg. 2013;41:258–64.PubMedCrossRef
30.
Ueda K, Oba S, Nakai K, Okada M, Kurokawa N, Nuri T. Functional reconstruction of the upper and lower lips and commissure with a forearm flap combined with a free gracilis muscle transfer. J Plast Reconstr Aesthet Surg. 2009;62:e337–40.PubMedCrossRef
31.
Ninkovic M, Sucur D, Starovic B, Markovic S. Arteriovenous fistulae after free flap surgery in a replanted hand. J Hand Surg Br. 1992;17:657–9.PubMedCrossRef
32.
Bit N, Vidyasagaran T, Amalorpavanathan J, Balakrishnan TM, Sritharan N. Management of a challenging arteriovenous malformation of the scalp and orbit in a patient with polycystic kidney disease. Ann Vasc Surg. 2012;26(1129):e9–11.
33.
Righi PD, Bade MA, Coleman JJ 3rd, Allen M. Arteriovenous malformation of the base of tongue: case report and literature review. Microsurgery. 1996;17:706–9.PubMedCrossRef
34.
Minagawa T, Itaya Y, Furukawa H. Resection of an arteriovenous malformation of the scalp using a modified tumescent technique. Nihon Keisei Geka Gakkai Kaishi. 2010;30:87–9.
35.
Suyama Y, Nakayama B, Fukuoka K, Takeuchi E, Hashimoto M, Kaminou T, et al. Auricular reconstruction with a free radial forearm flap for necrotized ear after sclerotherapy for arteriovenous malformation: a case report. Nihon Maikuro Sajari Gakkai Kaishi. 2010;23:311–5 (Japanese).
36.
Urayama H, Harada T, Kawase H, Watanabe Y. Surgical management of soft tissue arteriovenous malformations and hemangiomas. Shoni Geka. 1993;25:415–9 (Japanese).
37.
Yamamoto Y, Sugihara T, Minakawa H, Ohkubo Y, Hayashi T. Surgical treatment of massive arteriovenous malformation with application of hypothermia and cardiopulmonary bypass. Nihon Keisei Geka Gakkai Kaishi. 1996;16:863–71 (Japanese).
38.
Hormozi AK, Shafii MR. Supraclavicular flap: reconstructive strategy for massive facial arteriovenous malformations. J Craniofac Surg. 2011;22:931–6.PubMedCrossRef
39.
Hurwitz DJ, Kerber CW. Hemodynamic considerations in the treatment of arteriovenous malformations of the face and scalp. Plast Reconstr Surg. 1981;67:421–34.PubMedCrossRef
40.
Kiyokawa K, Takagi M, Fukushima J, Kizuka Y, Inoue Y, Tai Y. Surgical treatment following huge arteriovenous malformation extending from the lower lip to the chin: combination of embolization, total resection, and a double cross lip flap. J Craniofac Surg. 2005;16:443–8.PubMedCrossRef
41.
Thomas WO. Facial arteriovenous malformation managed with ablative surgery and dual rotational flap reconstruction. South Med J. 1994;87:1178–82.PubMedCrossRef
42.
Warwick DJ, Milling MA. Growth of a vascular malformation into a cross-finger flap. Br J Clin Pract. 1993;47:48.PubMed
43.
Agir H, Sen C, Onyedi M. Extended lateral supramalleolar flap for very distal foot coverage: a case with arteriovenous malformation. J Foot Ankle Surg. 2007;46:310–3.PubMedCrossRef
44.
Sakurai H, Nozaki M, Sasaki K, Yamaki T, Aiba H, Tohda J, et al. Successful management of a giant arteriovenous fistula with a combination of selective embolization and excision: report of a case. Surg Today. 2002;32:189–93.PubMedCrossRef
45.
Watanabe T, Asato H, Umekawa K, Nomura H, Suzuki Y. Resurfacing the index finger after resection of an arteriovenous malformation using a reverse forearm flap combined with additional venous anastomosis: a case report. Nihon Keisei Geka Gakkai Kaishi. 2012;32:335–9 (Japanese).
46.
Ishisaka T, Naitoh H, Akiyama K, Shigeyoshi N. A case of lower lip arteriovenous malformation with verrucous carcinoma. Nihon Keisei Geka Gakkai Kaishi. 2009;29:7–11 (Japanese).
47.
Kitagawa S, Kizaki K, Yajima H, Mii Y, Tamai S. Treatment of hemangiomas associated with arteriovenous fistulae in a family. Chubu Nihon Seikei Geka Saigai Geka Gakkai Zasshi. 1997;40:331–2 (Japanese).
48.
Gunji H, Suda K, Ono I, Ariga T, Kaneko F. Arteriovenous fistula of auricle treated with a temporoparietal fascial flap: a case report. Nihon Keisei Geka Gakkai Kaishi. 1993;13:221–7 (Japanese).
49.
Fujita A, Asada M, Saitoh M, Nakamura H, Hanagaki H, Ban M, et al. A case of congenital arteriovenous malformation of the scalp treated with rotation flap. No Shinkei Geka Janaru. 2000;9:86–91 (Japanese).
50.
Nakamura E, Suzuki S, Imagawa K, Akamatsu T, Miyasaka M. Experience of two patients with auricular arteriovenous malformation. Skin Surg. 2014;23:73–8 (Japanese).
51.
Yoshimura Y, Mizuno M, Kobayashi T, Oishi K, Maeda S, Hirano T, et al. Case reports: extracranial arteriovenous malformation. Hifuka No Rinsho. 2014;56:1180–3 (Japanese).
52.
Matsuzaki K, Nakamura T, Tahara T, Kashiwa H, Oshima H, Souzumi T. Congenital arteriovenous malformation of the auricle. Jibi Inkoka Tokeibu Geka. 1995;67:337–41 (Japanese).
53.
Schultz RC, Hermosillo CX. Congenital arteriovenous malformation of the face and scalp. Plast Reconstr Surg. 1980;65:496–501.PubMedCrossRef
54.
Slaba S, Herbreteau D, Jhaveri HS, Casasco A, Aymard A, Houdart E, et al. Therapeutic approach to arteriovenous malformations of the tongue. Eur Radiol. 1998;8:280–5.PubMedCrossRef
55.
Toker ME, Eren E, Akbayrak H, Numan F, Guler M, Balkanay M, et al. Combined approach to a peripheral congenital arteriovenous malformation: surgery and embolization. Heart Vessels. 2006;21:127–30.PubMedCrossRef
56.
Doppman JL, Pevsner P. Embolization of arteriovenous malformations by direct percutaneous puncture. AJR Am J Roentgenol. 1983;140:773–8.PubMedCrossRef
57.
Aikawa H, Okino Y, Yamada Y, Tomonari K, Gotoh T, Gotoh Y, et al. A review of embolization for arteriovenous malformations (fistulae). Oita Kenritsu Byoin Igaku Zasshi. 1997;26:77–82 (Japanese).
58.
Yamamoto T, Kanamura N, Tsukitani K, Hori N, Iehara T, Fukushima Y, et al. Direct embolization for a life-threatening mandibular arteriovenous malformation by means of hypothermic cardio-pulmonary arrest. Kyoto Furitsu Ika Daigaku Zasshi. 1999;108:981–94.
59.
Deng W, Huang D, Chen S, Zhang X, Li X, Li J, et al. Management of high-flow arteriovenous malformation in the maxillofacial region. J Craniofac Surg. 2010;21:916–9.PubMedCrossRef
60.
Erdmann MW, Jackson JE, Davies DM, Allison DJ. Multidisciplinary approach to the management of head and neck arteriovenous malformations. Ann R Coll Surg Engl. 1995;77:53–9.PubMedPubMedCentral
61.
Goldberg RA, Garcia GH, Duckwiler GR. Combined embolization and surgical treatment of arteriovenous malformation of the orbit. Am J Ophthalmol. 1993;116:17–25.PubMedCrossRef
62.
Persky MS, Yoo HJ, Berenstein A. Management of vascular malformations of the mandible and maxilla. Laryngoscope. 2003;113:1885–92.PubMedCrossRef
63.
Liu DG, Ma XC, Zhao FY, Zhang JG. A preliminary study of angiographic classification and its correlation to treatment of central arteriovenous malformation in the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:473–80.PubMedCrossRef
64.
Rodesch G, Soupre V, Vazquez MP, Alvarez H, Lasjaunias P. Arteriovenous malformations of the dental arcades. The place of endovascular therapy: results in 12 cases are presented. J Craniomaxillofac Surg. 1998;26:306–13.PubMedCrossRef
65.
Chen W, Wang J, Li J, Xu L. Comprehensive treatment of arteriovenous malformations in the oral and maxillofacial region. J Oral Maxillofac Surg. 2005;63:1484–8.PubMedCrossRef
66.
Chen WL, Ye JT, Xu LF, Huang ZQ, Zhang DM. A multidisciplinary approach to treating maxillofacial arteriovenous malformations in children. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:41–7.PubMedCrossRef
67.
Churojana A, Khumtong R, Songsaeng D, Chongkolwatana C, Suthipongchai S. Life-threatening arteriovenous malformation of the maxillomandibular region and treatment outcomes. Interv Neuroradiol. 2012;18:49–59.PubMedPubMedCentralCrossRef
68.
Liu D, Ma XC. Clinical study of embolization of arteriovenous malformation in the oral and maxillofacial region. Chin J Dent Res. 2000;3:63–70.PubMed
69.
Chandra RV, Leslie-Mazwi TM, Orbach DB, Kaban LB, Rabinov JD. Transarterial embolization of mandibular arteriovenous malformations using ONYX. J Oral Maxillofac Surg. 2014;72:1504–10.PubMedCrossRef
70.
Fifi J, Niimi Y, Berenstein A. Onyx embolization of an extensive mandibular arteriovenous malformation via a dual lumen balloon catheter: a technical case report. J Neurointerv Surg. 2013;5:e5.PubMedCrossRef
71.
Fan XD, Su LX, Zheng JW, Zheng LZ, Zhang ZY. Ethanol embolization of arteriovenous malformations of the mandible. AJNR Am J Neuroradiol. 2009;30:1178–83.PubMedPubMedCentralCrossRef
72.
Park HS, Do YS, Park KB, Kim DI, Kim YW, Kim MJ, et al. Ethanol embolotherapy of hand arteriovenous malformations. J Vasc Surg. 2011;53:725–31.PubMedCrossRef
73.
Park UJ, Do YS, Park KB, Park HS, Kim YW, Lee BB, et al. Treatment of arteriovenous malformations involving the hand. Ann Vasc Surg. 2012;26:643–8.PubMedCrossRef
74.
Hibino N, Hamada Y, Goda Y, Endo K, Yasui N, Kasai T, et al. Arterial graft for reconstruction after complete removal of the arteriovenous malformation. Nihon Maikuro Sajari Gakkai Kaishi. 2005;18:78–82.
75.
Widlus DM, Murray RR, White RI Jr, Osterman FA Jr, Schreiber ER, Satre RW, et al. Congenital arteriovenous malformations: tailored embolotherapy. Radiology. 1988;169:511–6.PubMedCrossRef
76.
Hattori Y, Doi K, Kawakami F, Watanabe M. Extended wrap-around flap for thumb reconstruction following radical excision of a congenital arteriovenous fistula. J Hand Surg Br. 1998;23:72–5.PubMedCrossRef
77.
Sugioka T, Sunagawa T, Suzuki O, Kijima Y, Ochi M. Surgical treatment for arteriovenous malformation involving the hand and forearm. Nihon Te No Geka Gakkai Zasshi. 2008;24:940–3 (Japanese).
78.
Furuya T, Nakazawa T. Congenital arteriovenous malformation of the index finger: a case report. Myakkangaku. 2009;49:430–3 (Japanese).
79.
Moore JR, Weiland AJ. Embolotherapy in the treatment of congenital arteriovenous malformations of the hand: a case report. J Hand Surg Am. 1985;10:135–9.PubMedCrossRef
80.
81.
Hein KD, Mulliken JB, Kozakewich HP, Upton J, Burrows PE. Venous malformations of skeletal muscle. Plast Reconstr Surg. 2002;110:1625–35.PubMedCrossRef
82.
Marler JJ, Mulliken JB. Current management of hemangiomas and vascular malformations. Clin Plast Surg. 2005;32:99–116 (ix).PubMedCrossRef
83.
Nguyen JT, Koerper MA, Hess CP, Dowd CF, Hoffman WY, Dickman M, et al. Aspirin therapy in venous malformation: a retrospective cohort study of benefits, side effects, and patient experiences. Pediatr Dermatol. 2014;31:556–60.PubMedCrossRef
84.
Shireman PK, McCarthy WJ, Yao JS, Vogelzang RL. Treatment of venous malformations by direct injection with ethanol. J Vasc Surg. 1997;26:838–44.PubMedCrossRef
85.
Rimon U, Garniek A, Galili Y, Golan G, Bensaid P, Morag B. Ethanol sclerotherapy of peripheral venous malformations. Eur J Radiol. 2004;52:283–7.PubMedCrossRef
86.
Marrocco-Trischitta MM, Nicodemi EM, Nater C, Stillo F. Management of congenital venous malformations of the vulva. Obstet Gynecol. 2001;98:789–93.PubMedCrossRef
87.
Suh JS, Shin KH, Na JB, Won JY, Hahn SB. Venous malformations: sclerotherapy with a mixture of ethanol and lipiodol. Cardiovasc Intervent Radiol. 1997;20:268–73.PubMedCrossRef
88.
Dompmartin A, Blaizot X, Théron J, Hammer F, Chene Y, Labbé D, et al. Radio-opaque ethylcellulose-ethanol is a safe and efficient sclerosing agent for venous malformations. Eur Radiol. 2011;21:2647–56.PubMedCrossRef
89.
Schumacher M, Dupuy P, Bartoli JM, Ernemann U, Herbreteau D, Ghienne C, et al. Treatment of venous malformations: first experience with a new sclerosing agent—a multicenter study. Eur J Radiol. 2011;80:e366–72.PubMedCrossRef
90.
Mimura H, Kanazawa S, Yasui K, Fujiwara H, Hyodo T, Mukai T, et al. Percutaneous sclerotherapy for venous malformations using polidocanol under fluoroscopy. Acta Med Okayama. 2003;57:227–34.PubMed
91.
Mimura H, Fujiwara H, Hiraki T, Gobara H, Mukai T, Hyodo T, et al. Polidocanol sclerotherapy for painful venous malformations: evaluation of safety and efficacy in pain relief. Eur Radiol. 2009;19:2474–80.PubMedCrossRef
92.
Cabrera J, Cabrera J Jr, Garcia-Olmedo MA, Redondo P. Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol. 2003;139:1409–16.PubMedCrossRef
93.
Ozaki M, Kurita M, Kaji N, Fujino T, Narushima M, Takushima A, et al. Efficacy and evaluation of safety of sclerosants for intramuscular venous malformations: clinical and experimental studies. Scand J Plast Reconstr Surg Hand Surg. 2010;44:75–87.PubMedCrossRef
94.
Krokidis M, Venetucci P, Hatzidakis A, Iaccarino V. Sodium tetradecyl sulphate direct intralesional sclerotherapy of venous malformations of the vulva and vagina: report of five cases. Cardiovasc Intervent Radiol. 2011;34(Suppl 2):S228–31.PubMedCrossRef
95.
Enjolras O, Ciabrini D, Mazoyer E, Laurian C, Herbreteau D. Extensive pure venous malformations in the upper or lower limb: a review of 27 cases. J Am Acad Dermatol. 1997;36:219–25.PubMedCrossRef
96.
Steiner F, FitzJohn T, Tan ST. Surgical treatment for venous malformation. J Plast Reconstr Aesthet Surg. 2013;66:1741–9.PubMedCrossRef
97.
Noel AA, Gloviczki P, Cherry KJ Jr, Rooke TW, Stanson AW, Driscoll DJ. Surgical treatment of venous malformations in Klippel-Trenaunay syndrome. J Vasc Surg. 2000;32:840–7.PubMedCrossRef
98.
Sidhu MK, Perkins JA, Shaw DW, Bittles MA, Andrews RT. Ultrasound-guided endovenous diode laser in the treatment of congenital venous malformations: preliminary experience. J Vasc Interv Radiol. 2005;16:879–84.PubMedCrossRef
99.
Lu X, Ye K, Shi H, Li W, Huang Y, Huang X, et al. Percutaneous endovenous treatment of congenital extratruncular venous malformations with an ultrasound-guided and 810-nm diode laser. J Vasc Surg. 2011;54:139–45.PubMedCrossRef
100.
Liu G, Liu X, Li W, Shi H, Ye K, Yin M, et al. Ultrasound-guided intralesional diode laser treatment of congenital extratruncular venous malformations: mid-term results. Eur J Vasc Endovasc Surg. 2014;47:558–64.PubMedCrossRef
101.
Mazoyer E, Enjolras O, Laurian C, Houdart E, Drouet L. Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach-Merritt syndrome. Clin Lab Haematol. 2002;24:243–51.PubMedCrossRef
102.
Cornelis F, Neuville A, Labreze C, Kind M, Bui B, Midy D, et al. Percutaneous cryotherapy of vascular malformation: initial experience. Cardiovasc Intervent Radiol. 2013;36:853–6.PubMedCrossRef
103.
Cornelis F, Havez M, Labreze C, Taieb A, Bui BN, Midy D, et al. Percutaneous cryoablation of symptomatic localized venous malformations: preliminary short-term results. J Vasc Interv Radiol. 2013;24:823–7.PubMedCrossRef
104.
Betz CS, Jager HR, Brookes JA, Richards R, Leunig A, Hopper C. Interstitial photodynamic therapy for a symptom-targeted treatment of complex vascular malformations in the head and neck region. Lasers Surg Med. 2007;39:571–82.PubMedCrossRef
105.
Bashkatov AN, Genina EA, Kochubey VI, Tuchin VV. Optical properties of human skin, subcutaneous and mucous tissues in the wavelength range from 400 to 2000 nm. J Phys D Appl Phys. 2005;38:2543–55.CrossRef
106.
Sarig O, Kimel S, Orenstein A. Laser treatment of venous malformations. Ann Plast Surg. 2006;57:20–4.PubMedCrossRef
107.
Vesnaver A, Dovsak DA. Treatment of vascular lesions in the head and neck using Nd:YAG laser. J Craniomaxillofac Surg. 2006;34:17–24.PubMedCrossRef
108.
Asai T, Suzuki H, Enomoto Y, Shigeoka M, Matsumoto K, Takeuchi J, et al. Clinical evaluation of 74 vascular malformations of the oral region treated by photocoagulation with an Nd:YAG laser. Nihon Reza Shigakkaishi. 2013;24:3–9 (Japanese).
109.
Ng EK, Cheung FK, Chiu PW. Blue rubber bleb nevus syndrome: treatment of multiple gastrointestinal hemangiomas with argon plasma coagulator. Dig Endosc. 2009;21:40–2.PubMedCrossRef
110.
Cholewa D, Waldschmidt J. Laser treatment of hemangiomas of the larynx and trachea. Lasers Surg Med. 1998;23:221–32.PubMedCrossRef
111.
Yakes WF, Haas DK, Parker SH, Gibson MD, Hopper KD, Mulligan JS, et al. Symptomatic vascular malformations: ethanol embolotherapy. Radiology. 1989;170:1059–66.PubMedCrossRef
112.
Lee IH, Kim KH, Jeon P, Byun HS, Kim HJ, Kim ST, et al. Ethanol sclerotherapy for the management of craniofacial venous malformations: the interim results. Korean J Radiol. 2009;10:269–76.PubMedPubMedCentralCrossRef
113.
Hoque S, Das BK. Treatment of venous malformations with ethanolamine oleate: a descriptive study of 83 cases. Pediatr Surg Int. 2011;27:527–31.PubMedCrossRef
114.
Stuart S, Barnacle AM, Smith G, Pitt M, Roebuck DJ. Neuropathy after sodium tetradecyl sulfate sclerotherapy of venous malformations in children. Radiology. 2015;274:897–905.PubMedCrossRef
115.
Zhao JH, Zhang WF, Zhao YF. Sclerotherapy of oral and facial venous malformations with use of pingyangmycin and/or sodium morrhuate. Int J Oral Maxillofac Surg. 2004;33:463–6.PubMedCrossRef
116.
Bai N, Chen YZ, Fu YJ, Wu P, Zhang WN. A clinical study of pingyangmycin sclerotherapy for venous malformation: an evaluation of 281 consecutive patients. J Clin Pharm Ther. 2014;39:521–6.PubMedCrossRef
117.
Goyal M, Causer PA, Armstrong D. Venous vascular malformations in pediatric patients: comparison of results of alcohol sclerotherapy with proposed MR imaging classification. Radiology. 2002;223:639–44.PubMedCrossRef
118.
Yun WS, Kim YW, Lee KB, Kim DI, Park KB, Kim KH, et al. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging. J Vasc Surg. 2009;50:581–9 (9 e1).PubMedCrossRef
119.
Rautio R, Saarinen J, Laranne J, Salenius JP, Keski-Nisula L. Endovascular treatment of venous malformations in extremities: results of sclerotherapy and the quality of life after treatment. Acta Radiol. 2004;45:397–403.PubMedCrossRef
120.
Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations. J Vasc Surg. 2008;47:578–84.PubMedCrossRef
121.
Nagao M, Sasaki S, Furukawa H, Saito N, Yamamoto Y. A clinical study of sclerotherapy for venous malformation of an upper extremity. Nihon Keisei Geka Gakkai Kaishi. 2012;32:463–8 (Japanese).
122.
Nomura T, Sakurai A, Nagata I, Terashi H, Tahara S. Our strategy for the treatment of venous malformations. Jomyakugaku. 2008;19:161–8 (Japanese).
123.
Qiu Y, Chen H, Lin X, Hu X, Jin Y, Ma G. Outcomes and complications of sclerotherapy for venous malformations. Vasc Endovascular Surg. 2013;47:454–61.PubMedCrossRef
124.
Wong GA, Armstrong DC, Robertson JM. Cardiovascular collapse during ethanol sclerotherapy in a pediatric patient. Paediatr Anaesth. 2006;16:343–6.PubMedCrossRef
125.
Tachibana K, Kobayashi S, Kojima T, Kaseno S, Kemmotsu O. Pulmonary emboli in sclerotherapy for peripheral vascular malformations under general anesthesia; a report of two cases. Masui. 2004;53:645–9 (Japanese).PubMed
126.
Marrocco-Trischitta MM, Guerrini P, Abeni D, Stillo F. Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation. Dermatol Surg. 2002;28:153–5.PubMed
127.
Shimo T, Hidaka K, Yanagawa S, Kadota W, Kawakami S, Tsuchida H. Two episodes of cardiac arrest in a boy receiving sclerotherapy with polydocanol—a case report. Masui. 2005;54:57–9 (Japanese).PubMed
128.
Schild SE, Buskirk SJ, Frick LM, Cupps RE. Radiotherapy for large symptomatic hemangiomas. Int J Radiat Oncol Biol Phys. 1991;21:729–35.PubMedCrossRef
129.
Mitsuhashi N, Furuta M, Sakurai H, Takahashi T, Kato S, Nozaki M, et al. Outcome of radiation therapy for patients with Kasabach-Merritt syndrome. Int J Radiat Oncol Biol Phys. 1997;39:467–73.PubMedCrossRef
130.
Ogino I, Torikai K, Kobayasi S, Aida N, Hata M, Kigasawa H. Radiation therapy for life- or function-threatening infant hemangioma. Radiology. 2001;218:834–9.PubMedCrossRef
131.
Miller JG, Orton CI. Long term follow-up of a case of Kasabach-Merritt syndrome successfully treated with radiotherapy and corticosteroids. Br J Plast Surg. 1992;45:559–61.PubMedCrossRef
132.
Frevel T, Rabe H, Uckert F, Harms E. Giant cavernous haemangioma with Kasabach-Merritt syndrome: a case report and review. Eur J Pediatr. 2002;161:243–6.PubMedCrossRef
133.
Stringel G, Mercer S. Giant hemangioma in the newborn and infant. Complications and management. Clin Pediatr (Phila). 1984;23:498–502.PubMedCrossRef
134.
Enjolras O, Wassef M, Mazoyer E, Frieden IJ, Rieu PN, Drouet L, et al. Infants with Kasabach-Merritt syndrome do not have “true” hemangiomas. J Pediatr. 1997;130:631–40.PubMedCrossRef
135.
Lundell M, Mattsson A, Hakulinen T, Holm LE. Breast cancer after radiotherapy for skin hemangioma in infancy. Radiat Res. 1996;145:225–30.PubMedCrossRef
136.
Haddy N, Andriamboavonjy T, Paoletti C, Dondon MG, Mousannif A, Shamsaldin A, et al. Thyroid adenomas and carcinomas following radiotherapy for a hemangioma during infancy. Radiother Oncol. 2009;93:377–82.PubMedCrossRef
137.
Caldwell JB, Ryan MT, Benson PM, James WD. Cutaneous angiosarcoma arising in the radiation site of a congenital hemangioma. J Am Acad Dermatol. 1995;33:865–70.PubMedCrossRef
138.
Oguri A, Oda M, Yokoo K. The relation between age and the effectiveness of laser treatment for capillary malformation. Nihon Keisei Geka Gakkai Kaishi. 2009;29:407–11 (Japanese).
139.
Reynolds N, Exley J, Hills S, Falder S, Duff C, Kenealy J. The role of the Lumina intense pulsed light system in the treatment of port wine stains—a case controlled study. Br J Plast Surg. 2005;58:968–80.PubMedCrossRef
140.
Katugampola GA, Lanigan SW. Five years’ experience of treating port wine stains with the flashlamp-pumped pulsed dye laser. Br J Dermatol. 1997;137:750–4.PubMedCrossRef
141.
Minato S. Comparison between results of treatment with dye laser and argon laser in cases of hemangioma simplex. Iwate Igaku Zasshi. 1997;49:299–302.
142.
Ryuzaki K, Tamura A, Amano H, Takeuchi Y, Ishikawa O, Miyachi Y. An overview of dye laser treatment for superficial hemangiomas at the Department of Dermatology, Gunma University. Hifuka Kiyo. 1996;91:41–6 (Japanese).
143.
Matsumoto T. Comparative study in laser treatment of portwine stains with dye and argon lasers. Part 2: statistical study of clinical effects. Nihon Keisei Geka Gakkai Kaishi. 1996;16:246–59 (Japanese).
144.
Fitzpatrick RE, Lowe NJ, Goldman MP, Borden H, Behr KL, Ruiz-Esparza J. Flashlamp-pumped pulsed dye laser treatment of port-wine stains. J Dermatol Surg Oncol. 1994;20:743–8.PubMedCrossRef
145.
Morikawa K, Yamauchi K, Saheki M, Tezuka T. Treatment of portwine stain using pulsed dye laser: comparison of effectiveness with location of lesion, age and wavelength. Hifu. 1994;36:514–21 (Japanese).
146.
Matsushita Y, Suzuki S, Koyama H, Akamatsu J, Kawata Y, Kawai K. Treatment of portwine stains with dye lasers. Hifuka Kiyo. 1994;89:205–10 (Japanese).
147.
Namba Y, Mae O, Nagase Y, Ao M, Hamaya K, Nose S. Dye laser treatment of cutaneous simple hemangioma. Okayama Saiseikai Sogo Byoin Zasshi. 1991;22:1–10 (Japanese).
148.
Bandoh Y, Yanai A, Tsuzuki K. Dye laser treatment of port-wine stains. Aesthetic Plast Surg. 1990;14:287–91.PubMedCrossRef
149.
Bandoh Y. Pulsed dye laser treatment for port-wine stains. Rinsho Hifuka. 1989;43:1337–40 (Japanese).
150.
Renfro L, Geronemus RG. Anatomical differences of port-wine stains in response to treatment with the pulsed dye laser. Arch Dermatol. 1993;129:182–8.PubMedCrossRef
151.
Lanigan SW. Port wine stains on the lower limb: response to pulsed dye laser therapy. Clin Exp Dermatol. 1996;21:88–92.PubMedCrossRef
152.
Sommer S, Seukeran DC, Sheehan-Dare RA. Efficacy of pulsed dye laser treatment of port wine stain malformations of the lower limb. Br J Dermatol. 2003;149:770–5.PubMedCrossRef
153.
Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124:869–71.PubMedCrossRef
154.
Wareham WJ, Cole RP, Royston SL, Wright PA. Adverse effects reported in pulsed dye laser treatment for port wine stains. Lasers Med Sci. 2009;24:241–6.PubMedCrossRef
155.
Orten SS, Waner M, Flock S, Roberson PK, Kincannon J. Port-wine stains. An assessment of 5 years of treatment. Arch Otolaryngol Head Neck Surg. 1996;122:1174–9.PubMedCrossRef
156.
Michel S, Landthaler M, Hohenleutner U. Recurrence of port-wine stains after treatment with the flashlamp-pumped pulsed dye laser. Br J Dermatol. 2000;143:1230–4.PubMedCrossRef
157.
Soueid A, Waters R. Re-emergence of port wine stains following treatment with flashlamp-pumped dye laser 585 nm. Ann Plast Surg. 2006;57:260–3.PubMedCrossRef
158.
Huikeshoven M, Koster PH, de Borgie CA, Beek JF, van Gemert MJ, van der Horst CM. Redarkening of port-wine stains 10 years after pulsed-dye-laser treatment. N Engl J Med. 2007;356:1235–40.PubMedCrossRef
159.
Phung TL, Oble DA, Jia W, Benjamin LE, Mihm MC Jr, Nelson JS. Can the wound healing response of human skin be modulated after laser treatment and the effects of exposure extended? Implications on the combined use of the pulsed dye laser and a topical angiogenesis inhibitor for treatment of port wine stain birthmarks. Lasers Surg Med. 2008;40:1–5.PubMedPubMedCentralCrossRef
160.
Babilas P, Shafirstein G, Bäumler W, Baier J, Landthaler M, Szeimies RM, et al. Selective photothermolysis of blood vessels following flashlamp-pumped pulsed dye laser irradiation: in vivo results and mathematical modelling are in agreement. J Invest Dermatol. 2005;125:343–52.PubMedCrossRef
161.
Laquer VT, Hevezi PA, Albrecht H, Chen TS, Zlotnik A, Kelly KM. Microarray analysis of port wine stains before and after pulsed dye laser treatment. Lasers Surg Med. 2013;45:67–75.PubMedPubMedCentralCrossRef
162.
Chapas AM, Eickhorst K, Geronemus RG. Efficacy of early treatment of facial port wine stains in newborns: a review of 49 cases. Lasers Surg Med. 2007;39:563–8.PubMedCrossRef
163.
Jia W, Sun V, Tran N, Choi B, Liu SW, Mihm MC Jr, et al. Long-term blood vessel removal with combined laser and topical rapamycin antiangiogenic therapy: implications for effective port wine stain treatment. Lasers Surg Med. 2010;42:105–12.PubMedPubMedCentralCrossRef
164.
Chang CJ, Hsiao YC, Mihm MC Jr, Nelson JS. Pilot study examining the combined use of pulsed dye laser and topical Imiquimod versus laser alone for treatment of port wine stain birthmarks. Lasers Surg Med. 2008;40:605–10.PubMedPubMedCentralCrossRef
165.
Tremaine AM, Armstrong J, Huang YC, Elkeeb L, Ortiz A, Harris R, et al. Enhanced port-wine stain lightening achieved with combined treatment of selective photothermolysis and imiquimod. J Am Acad Dermatol. 2012;66:634–41.PubMedPubMedCentralCrossRef
166.
Nguyen CM, Yohn JJ, Huff C, Weston WL, Morelli JG. Facial port wine stains in childhood: prediction of the rate of improvement as a function of the age of the patient, size and location of the port wine stain and the number of treatments with the pulsed dye (585 nm) laser. Br J Dermatol. 1998;138:821–5.PubMedCrossRef
167.
van der Horst CM, Koster PH, de Borgie CA, Bossuyt PM, van Gemert MJ. Effect of the timing of treatment of port-wine stains with the flash-lamp-pumped pulsed-dye laser. N Engl J Med. 1998;338:1028–33.PubMedCrossRef
168.
Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358:2649–51.PubMedCrossRef
169.
Broeks IJ, Hermans DJ, Dassel AC, van der Vleuten CJ, van Beynum IM. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature. Int J Pediatr Otorhinolaryngol. 2013;77:1791–800.PubMedCrossRef
170.
171.
Zvulunov A, McCuaig C, Frieden IJ, Mancini AJ, Puttgen KB, Dohil M, et al. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study. Pediatr Dermatol. 2011;28:94–8.PubMedCrossRef
172.
Hermans DJ, van Beynum IM, Schultze Kool LJ, van de Kerkhof PC, Wijnen MH, van der Vleuten CJ. Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls. J Am Acad Dermatol. 2011;64:833–8.PubMedCrossRef
173.
Saint-Jean M, Léauté-Labrèze C, Mazereeuw-Hautier J, Bodak N, Hamel-Teillac D, Kupfer-Bessaguet I, et al. Propranolol for treatment of ulcerated infantile hemangiomas. J Am Acad Dermatol. 2011;64:827–32.PubMedCrossRef
174.
Caussé S, Aubert H, Saint-Jean M, Puzenat E, Bursztejn AC, Eschard C, et al. Propranolol-resistant infantile haemangiomas. Br J Dermatol. 2013;169:125–9.PubMedCrossRef
175.
Vassallo P, Forte R, Di Mezza A, Magli A. Treatment of infantile capillary hemangioma of the eyelid with systemic propranolol. Am J Ophthalmol. 2013;155(165–70):e2.
176.
Lynch M, Lenane P, O’Donnell BF. Propranolol for the treatment of infantile haemangiomas: our experience with 44 patients. Clin Exp Dermatol. 2014;39:142–5.PubMedCrossRef
177.
Price CJ, Lattouf C, Baum B, McLeod M, Schachner LA, Duarte AM, et al. Propranolol vs corticosteroids for infantile hemangiomas: a multicenter retrospective analysis. Arch Dermatol. 2011;147:1371–6.PubMedCrossRef
178.
Hermans DJ, Bauland CG, Zweegers J, van Beynum IM, van der Vleuten CJ. Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions. Br J Dermatol. 2013;168:837–43.PubMedCrossRef
179.
de Graaf M, Breur J, Raphael MF, Vos M, Breugem CC, Pasmans S. Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants. J Am Acad Dermatol. 2011;65:320–7.PubMedCrossRef
180.
Hogeling M, Adams S, Wargon O. A randomized controlled trial of propranolol for infantile hemangiomas. Pediatrics. 2011;128:e259–66.PubMedCrossRef
181.
Zaher H, Rasheed H, Esmat S, Hegazy RA, Gawdat HI, Hegazy RA, et al. Propranolol and infantile hemangiomas: different routes of administration, a randomized clinical trial. Eur J Dermatol. 2013;23:646–52.PubMedCrossRef
182.
Malik MA, Menon P, Rao KL, Samujh R. Effect of propranolol vs prednisolone vs propranolol with prednisolone in the management of infantile hemangioma: a randomized controlled study. J Pediatr Surg. 2013;48:2453–9.PubMedCrossRef
183.
Bauman NM, McCarter RJ, Guzzetta PC, Shin JJ, Oh AK, Preciado DA, et al. Propranolol vs prednisolone for symptomatic proliferating infantile hemangiomas: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2014;140:323–30.PubMedCrossRef
184.
Léauté-Labrèze C, Dumas de la Roque E, Nacka F, Abouelfath A, Grenier N, Rebola M, et al. Double-blind randomized pilot trial evaluating the efficacy of oral propranolol on infantile haemangiomas in infants < 4 months of age. Br J Dermatol. 2013;169:181–3.PubMedCrossRef
185.
Abarzúa-Araya A, Navarrete-Dechent CP, Heusser F, Retamal J, Zegpi-Trueba MS. Atenolol versus propranolol for the treatment of infantile hemangiomas: a randomized controlled study. J Am Acad Dermatol. 2014;70:1045–9.PubMedCrossRef
186.
Ehsani AH, Noormohammadpoor P, Abdolreza M, Balighi K, Arianian Z, Daklan S. Combination therapy of infantile hemangioma with pulsed dye laser with topical propranolol: a randomized clinical trial. Arch Iran Med. 2014;17:657–60.PubMed
187.
Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015;372:735–46.PubMedCrossRef
188.
Menezes MD, McCarter R, Greene EA, Bauman NM. Status of propranolol for treatment of infantile hemangioma and description of a randomized clinical trial. Ann Otol Rhinol Laryngol. 2011;120:686–95.PubMedCrossRef
189.
Marqueling AL, Oza V, Frieden IJ, Puttgen KB. Propranolol and infantile hemangiomas four years later: a systematic review. Pediatr Dermatol. 2013;30:182–91.PubMedCrossRef
190.
Xu SQ, Jia RB, Zhang W, Zhu H, Ge SF, Fan XQ. Beta-blockers versus corticosteroids in the treatment of infantile hemangioma: an evidence-based systematic review. World J Pediatr. 2013;9:221–9.PubMedCrossRef
191.
Izadpanah A, Izadpanah A, Kanevsky J, Belzile E, Schwarz K. Propranolol versus corticosteroids in the treatment of infantile hemangioma: a systematic review and meta-analysis. Plast Reconstr Surg. 2013;131:601–13.PubMedCrossRef
192.
Xu S, Jia R, Ge S, Lin M, Fan X. Treatment of periorbital infantile haemangiomas: a systematic literature review on propranolol or steroids. J Paediatr Child Health. 2014;50:271–9.PubMedCrossRef
193.
Peridis S, Pilgrim G, Athanasopoulos I, Parpounas K. A meta-analysis on the effectiveness of propranolol for the treatment of infantile airway haemangiomas. Int J Pediatr Otorhinolaryngol. 2011;75:455–60.PubMedCrossRef
194.
Vlastarakos PV, Papacharalampous GX, Chrysostomou M, Tavoulari EF, Delidis A, Protopapas D, et al. Propranolol is an effective treatment for airway haemangiomas: a critical analysis and meta-analysis of published interventional studies. Acta Otorhinolaryngol Ital. 2012;32:213–21.PubMedPubMedCentral
195.
Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol. 2010;163:269–74.PubMedCrossRef
196.
Drolet BA, Frommelt PC, Chamlin SL, Haggstrom A, Bauman NM, Chiu YE, et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013;131:128–40.PubMedPubMedCentralCrossRef
197.
Kum JJ, Khan ZA. Mechanisms of propranolol action in infantile hemangioma. Dermatoendocrinology. 2014;6:e979699.CrossRef
198.
Horev A, Haim A, Zvulunov A. Propranolol induced hypoglycemia. Pediatr Endocrinol Rev. 2015;12:308–10.PubMed
199.
Blei F, McElhinney DB, Guarini A, Presti S. Cardiac screening in infants with infantile hemangiomas before propranolol treatment. Pediatr Dermatol. 2014;31:465–70.PubMedCrossRef
200.
Raphael MF, Breugem CC, Vlasveld FA, de Graaf M, Slieker MG, Pasmans SG, et al. Is cardiovascular evaluation necessary prior to and during beta-blocker therapy for infantile hemangiomas?: a cohort study. J Am Acad Dermatol. 2015;72:465–72.PubMedCrossRef
201.
Chamlin SL, Haggstrom AN, Drolet BA, Baselga E, Frieden IJ, Garzon MC, et al. Multicenter prospective study of ulcerated hemangiomas. J Pediatr. 2007;151:684–9 (9 e1).PubMedCrossRef
202.
Vercellino N, Romanini MV, Pelegrini M, Rimini A, Occella C, Dalmonte P. The use of propranolol for complicated infantile hemangiomas. Int J Dermatol. 2013;52:1140–6.PubMedCrossRef
203.
Sadykov RR, Podmelle F, Sadykov RA, Kasimova KR, Metellmann HR. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region. Int J Oral Maxillofac Surg. 2013;42:863–7.PubMedCrossRef
204.
Kim HJ, Colombo M, Frieden IJ. Ulcerated hemangiomas: clinical characteristics and response to therapy. J Am Acad Dermatol. 2001;44:962–72.PubMedCrossRef
205.
Wananukul S, Chatproedprai S. Ulcerated hemangiomas: clinical features and management. J Med Assoc Thai. 2002;85:1220–5.PubMed
206.
Pandey A, Gangopadhyay AN, Sharma SP, Kumar V, Gopal SC, Gupta DK. Conservative management of ulcerated haemangioma—twenty years experience. Int Wound J. 2009;6:59–62.PubMedPubMedCentralCrossRef
207.
Oranje AP, de Waard-van der Spek FB, Devillers AC, de Laat PC, Madern GC. Treatment and pain relief of ulcerative hemangiomas with a polyurethane film. Dermatology. 2000;200:31–4.PubMedCrossRef
208.
Bauland CG, Smit JM, Ketelaars R, Rieu PN, Spauwen PH. Management of haemangiomas of infancy: a retrospective analysis and a treatment protocol. Scand J Plast Reconstr Surg Hand Surg. 2008;42:86–91.PubMedCrossRef
209.
Morelli JG, Tan OT, Yohn JJ, Weston WL. Treatment of ulcerated hemangiomas infancy. Arch Pediatr Adolesc Med. 1994;148:1104–5.PubMedCrossRef
210.
Lacour M, Syed S, Linward J, Harper JI. Role of the pulsed dye laser in the management of ulcerated capillary haemangiomas. Arch Dis Child. 1996;74:161–3.PubMedPubMedCentralCrossRef
211.
David LR, Malek MM, Argenta LC. Efficacy of pulse dye laser therapy for the treatment of ulcerated haemangiomas: a review of 78 patients. Br J Plast Surg. 2003;56:317–27.PubMedCrossRef
212.
Michel JL. Treatment of hemangiomas with 595 nm pulsed dye laser dermobeam. Eur J Dermatol. 2003;13:136–41.PubMed
213.
Di Maio L, Baldi A, Dimaio V, Barzi A. Use of flashlamp-pumped pulsed dye laser in the treatment of superficial vascular malformations and ulcerated hemangiomas. In Vivo. 2011;25:117–23.PubMed
214.
Sugarman JL, Mauro TM, Frieden IJ. Treatment of an ulcerated hemangioma with recombinant platelet-derived growth factor. Arch Dermatol. 2002;138:314–6.PubMedCrossRef
215.
Metz BJ, Rubenstein MC, Levy ML, Metry DW. Response of ulcerated perineal hemangiomas of infancy to becaplermin gel, a recombinant human platelet-derived growth factor. Arch Dermatol. 2004;140:867–70.PubMedCrossRef
216.
Jalil S, Akhtar J, Ahmed S. Corticosteroids therapy in the management of infantile cutaneous hemangiomas. J Coll Physicians Surg Pak. 2006;16:662–5.PubMed
217.
Gangopadhyay AN, Sinha CK, Gopal SC, Gupta DK, Sahoo SP, Ahmad M. Role of steroid in childhood haemangioma: a 10 years review. Int Surg. 1997;82:49–51.PubMed
218.
Pandey A, Gangopadhyay AN, Gopal SC, Kumar V, Sharma SP, Gupta DK, et al. Twenty years’ experience of steroids in infantile hemangioma—a developing country’s perspective. J Pediatr Surg. 2009;44:688–94.PubMedCrossRef
219.
Tan BH, Leadbitter PH, Aburn NH, Tan ST. Steroid therapy for problematic proliferating haemangioma. N Z Med J. 2011;124:57–65.PubMed
220.
Ruttum MS, Abrams GW, Harris GJ, Ellis MK. Bilateral retinal embolization associated with intralesional corticosteroid injection for capillary hemangioma of infancy. J Pediatr Ophthalmol Strabismus. 1993;30:4–7.PubMedCrossRef
221.
Egbert JE, Schwartz GS, Walsh AW. Diagnosis and treatment of an ophthalmic artery occlusion during an intralesional injection of corticosteroid into an eyelid capillary hemangioma. Am J Ophthalmol. 1996;121:638–42.PubMedCrossRef
222.
Craiglow BG, Antaya RJ. Management of infantile hemangiomas: current and potential pharmacotherapeutic approaches. Paediatr Drugs. 2013;15:133–8.PubMedCrossRef
223.
Ni N, Langer P, Wagner R, Guo S. Topical timolol for periocular hemangioma: report of further study. Arch Ophthalmol. 2011;129:377–9.PubMedCrossRef
224.
Elsas FJ, Lewis AR. Topical treatment of periocular capillary hemangioma. J Pediatr Ophthalmol Strabismus. 1994;31:153–6.PubMedCrossRef
225.
Lapidoth M, Ben-Amitai D, Bhandarkar S, Fried L, Arbiser JL. Efficacy of topical application of eosin for ulcerated hemangiomas. J Am Acad Dermatol. 2009;60:350–1.PubMedCrossRef
226.
Barry RB, Hughes BR, Cook LJ. Involution of infantile haemangiomas after imiquimod 5% cream. Clin Exp Dermatol. 2008;33:446–9.PubMedCrossRef
227.
Ho NT, Lansang P, Pope E. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study. J Am Acad Dermatol. 2007;56:63–8.PubMedCrossRef
228.
Jiang C, Hu X, Ma G, Chen D, Jin Y, Chen H, et al. A prospective self-controlled phase II study of imiquimod 5% cream in the treatment of infantile hemangioma. Pediatr Dermatol. 2011;28:259–66.PubMedCrossRef
229.
Mao XH, Wang JY, Yan JL. Topical imiquimod treatment of cutaneous vascular disorders in pediatric patients: clinical evaluation on the efficacy and safety. J Zhejiang Univ Sci B. 2012;13:745–50.PubMedPubMedCentralCrossRef
230.
McCuaig CC, Dubois J, Powell J, Belleville C, David M, Rousseau E, et al. A phase II, open-label study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma. Pediatr Dermatol. 2009;26:203–12.PubMedCrossRef
231.
Qiu Y, Ma G, Lin X, Jin Y, Chen H, Hu X. Treating protruding infantile hemangiomas with topical imiquimod 5% cream caused severe local reactions and disfiguring scars. Pediatr Dermatol. 2013;30:342–7.PubMedCrossRef
232.
Qiu Y, Ma G, Yang J, Hu X, Chen H, Jin Y, et al. Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study. Clin Exp Dermatol. 2013;38:845–50.PubMedCrossRef
233.
Welsh O, Olazaran Z, Gomez M, Salas J, Berman B. Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream. J Am Acad Dermatol. 2004;51:639–42.PubMedCrossRef
234.
Blatt J, Morrell DS, Buck S, Zdanski C, Gold S, Stavas J, et al. β-blockers for infantile hemangiomas: a single-institution experience. Clin Pediatr (Phila). 2011;50:757–63.PubMedCrossRef
235.
Cante V, Pham-Ledard A, Imbert E, Ezzedine K, Léauté-Labrèze C. First report of topical timolol treatment in primarily ulcerated perineal haemangioma. Arch Dis Child Fetal Neonatal Ed. 2012;97:F155–6.PubMedCrossRef
236.
Chakkittakandiyil A, Phillips R, Frieden IJ, Siegfried E, Lara-Corrales I, Lam J, et al. Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study. Pediatr Dermatol. 2012;29:28–31.PubMedCrossRef
237.
Chambers CB, Katowitz WR, Katowitz JA, Binenbaum G. A controlled study of topical 0.25% timolol maleate gel for the treatment of cutaneous infantile capillary hemangiomas. Ophthalmic Plast Reconstr Surg. 2012;28:103–6.PubMedCrossRef
238.
Khunger N, Pahwa M. Dramatic response to topical timolol lotion of a large hemifacial infantile haemangioma associated with PHACE syndrome. Br J Dermatol. 2011;164:886–8.PubMedCrossRef
239.
Ma G, Wu P, Lin X, Chen H, Hu X, Jin Y, et al. Fractional carbon dioxide laser-assisted drug delivery of topical timolol solution for the treatment of deep infantile hemangioma: a pilot study. Pediatr Dermatol. 2014;31:286–91.PubMedCrossRef
240.
Moehrle M, Léauté-Labrèze C, Schmidt V, Röcken M, Poets CF, Goelz R. Topical timolol for small hemangiomas of infancy. Pediatr Dermatol. 2013;30:245–9.PubMedCrossRef
241.
Ni N, Guo S, Langer P. Current concepts in the management of periocular infantile (capillary) hemangioma. Curr Opin Ophthalmol. 2011;22:419–25.PubMedCrossRef
242.
Oranje AP, Janmohamed SR, Madern GC, de Laat PC. Treatment of small superficial haemangioma with timolol 0.5% ophthalmic solution: a series of 20 cases. Dermatology. 2011;223:330–4.PubMedCrossRef
243.
Pope E, Chakkittakandiyil A. Topical timolol gel for infantile hemangiomas: a pilot study. Arch Dermatol. 2010;146:564–5.PubMedCrossRef
244.
Kunzi-Rapp K. Topical propranolol therapy for infantile hemangiomas. Pediatr Dermatol. 2012;29:154–9.PubMedCrossRef
245.
Xu G, Lv R, Zhao Z, Huo R. Topical propranolol for treatment of superficial infantile hemangiomas. J Am Acad Dermatol. 2012;67:1210–3.PubMedCrossRef
246.
Garzon MC, Lucky AW, Hawrot A, Frieden IJ. Ultrapotent topical corticosteroid treatment of hemangiomas of infancy. J Am Acad Dermatol. 2005;52:281–6.PubMedCrossRef
247.
Pandey A, Gangopadhyay AN, Sharma SP, Kumar V, Gupta DK, Gopal SC. Evaluation of topical steroids in the treatment of superficial hemangioma. Skinmed. 2010;8:9–11.PubMed
248.
Kaplan M, Paller AS. Clinical pearl: use of self-adhesive, compressive wraps in the treatment of limb hemangiomas. J Am Acad Dermatol. 1995;32:117–8.PubMedCrossRef
249.
Ochi G, Ohkawa H, Kaneko M, Hori T, Shinoda M, Kojima M, et al. Compression therapy and cryosurgery for hemangiomas in childhood. Shoni Geka. 1992;24:539–47 (Japanese).
250.
Totsuka Y, Fukuda H, Tomita K. Compression therapy for parotid haemangioma in infants. A report of three cases. J Craniomaxillofac Surg. 1988;16:366–70.PubMedCrossRef
251.
Osaki TH, Jakobiec FA, Mendoza PR, Lee Y, Fay AM. Immunohistochemical investigations of orbital infantile hemangiomas and adult encapsulated cavernous venous lesions (malformation versus hemangioma). Ophthalmic Plast Reconstr Surg. 2013;29:183–95.PubMedCrossRef
252.
Laing EL, Brasch HD, Steel R, Jia J, Itinteang T, Tan ST, et al. Verrucous hemangioma expresses primitive markers. J Cutan Pathol. 2013;40:391–6.PubMedCrossRef
253.
North PE, Waner M, James CA, Mizeracki A, Frieden IJ, Mihm MC Jr. Congenital nonprogressive hemangioma: a distinct clinicopathologic entity unlike infantile hemangioma. Arch Dermatol. 2001;137:1607–20.PubMedCrossRef
254.
North PE, Waner M, Mizeracki A, Mihm MC Jr. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol. 2000;31:11–22.PubMedCrossRef
255.
North PE, Waner M, Mizeracki A, Mrak RE, Nicholas R, Kincannon J, et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol. 2001;137:559–70.PubMedCrossRef
256.
Leon-Villapalos J, Wolfe K, Kangesu L. GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations. Br J Plast Surg. 2005;58:348–52.PubMedCrossRef
257.
Ahrens WA, Ridenour RV 3rd, Caron BL, Miller DV, Folpe AL. GLUT-1 expression in mesenchymal tumors: an immunohistochemical study of 247 soft tissue and bone neoplasms. Hum Pathol. 2008;39:1519–26.PubMedCrossRef
258.
Trindade F, Kutzner H, Requena L, Tellechea O, Colmenero I. Microvenular hemangioma—an immunohistochemical study of 9 cases. Am J Dermatopathol. 2012;34:810–2.PubMedCrossRef
259.
Sadeghpour M, Antaya RJ, Lazova R, Ko CJ. Dilated lymphatic vessels in tufted angioma: a potential source of diagnostic confusion. Am J Dermatopathol. 2012;34:400–3.PubMedCrossRef
260.
261.
Lyons LL, North PE, Mac-Moune Lai F, Stoler MH, Folpe AL, Weiss SW. Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol. 2004;28:559–68.PubMedCrossRef
262.
Al-Adnani M, Williams S, Rampling D, Ashworth M, Malone M, Sebire NJ. Histopathological reporting of paediatric cutaneous vascular anomalies in relation to proposed multidisciplinary classification system. J Clin Pathol. 2006;59:1278–82.PubMedPubMedCentralCrossRef
263.
Badi AN, Kerschner JE, North PE, Drolet BA, Messner A, Perkins JA. Histopathologic and immunophenotypic profile of subglottic hemangioma: multicenter study. Int J Pediatr Otorhinolaryngol. 2009;73:1187–91.PubMedCrossRef
264.
Hernandez F, Navarro M, Encinas JL, Lopez Gutierrez JC, Lopez Santamaria M, Leal N, et al. The role of GLUT1 immunostaining in the diagnosis and classification of liver vascular tumors in children. J Pediatr Surg. 2005;40:801–4.PubMedCrossRef
265.
Mo JQ, Dimashkieh HH, Bove KE. GLUT1 endothelial reactivity distinguishes hepatic infantile hemangioma from congenital hepatic vascular malformation with associated capillary proliferation. Hum Pathol. 2004;35:200–9.PubMedCrossRef
266.
Das KJ, Sharma P, Naswa N, Soundararajan R, Kumar R, Bal C, et al. Hybrid SPECT-CT with 99 mTc-labeled red blood cell in a case of blue rubber bleb nevus syndrome: added value over planar scintigraphy. Diagn Interv Radiol. 2013;19:41–3.PubMed
267.
Senturk S, Bilici A, Miroglu TC, Bilek SU. Blue rubber bleb nevus syndrome: imaging of small bowel lesions with peroral CT enterography. Abdom Imaging. 2011;36:520–3.PubMedCrossRef
268.
Thomson M, Venkatesh K, Elmalik K, van der Veer W, Jaacobs M. Double balloon enteroscopy in children: diagnosis, treatment, and safety. World J Gastroenterol. 2010;16:56–62.PubMedPubMedCentralCrossRef
269.
Agnese M, Cipolletta L, Bianco MA, Quitadamo P, Miele E, Staiano A. Blue rubber bleb nevus syndrome. Acta Paediatr. 2010;99:632–5.PubMedCrossRef
270.
Hansen LF, Wewer V, Pedersen SA, Matzen P, Paerregaard A. Severe blue rubber bleb nevus syndrome in a neonate. Eur J Pediatr Surg. 2009;19:47–9.PubMedCrossRef
271.
Yarlagadda R, Menda Y, Graham MM. Tc-99m red blood cell imaging in a patient with blue rubber bleb nevus syndrome. Clin Nucl Med. 2008;33:374–6.PubMedCrossRef
272.
Mechri M, Soyer P, Boudiaf M, Duchat F, Hamzi L, Rymer R. Small bowel involvement in blue rubber bleb nevus syndrome: MR imaging features. Abdom Imaging. 2009;34:448–51.PubMedCrossRef
273.
Certo M, Lopes L, Ramada J. Blue rubber bleb nevus syndrome: manifestations at computed tomography. Acta Radiol. 2007;48:962–6.PubMedCrossRef
274.
Kopacova M, Tacheci I, Koudelka J, Kralova M, Rejchrt S, Bures J. A new approach to blue rubber bleb nevus syndrome: the role of capsule endoscopy and intra-operative enteroscopy. Pediatr Surg Int. 2007;23:693–7.PubMedCrossRef
275.
De Bona M, Bellumat A, De Boni M. Capsule endoscopy for the diagnosis and follow-up of blue rubber bleb nevus syndrome. Dig Liver Dis. 2005;37:451–3.PubMedCrossRef
276.
Place RJ. Blue rubber bleb nevus syndrome: a case report with long-term follow-up. Mil Med. 2001;166:728–30.PubMedCrossRef
277.
Jacob AG, Driscoll DJ, Shaughnessy WJ, Stanson AW, Clay RP, Gloviczki P. Klippel-Trenaunay syndrome: spectrum and management. Mayo Clin Proc. 1998;73:28–36.PubMedCrossRef
278.
Capraro PA, Fisher J, Hammond DC, Grossman JA. Klippel-Trenaunay syndrome. Plast Reconstr Surg. 2002;109:2052–60 (quiz 61–2).PubMedCrossRef
279.
Meine JG, Schwartz RA, Janniger CK. Klippel-Trenaunay-Weber syndrome. Cutis. 1997;60:127–32.PubMed
280.
Redondo P, Aguado L, Martinez-Cuesta A. Diagnosis and management of extensive vascular malformations of the lower limb: part II Systemic repercussions [corrected], diagnosis, and treatment. J Am Acad Dermatol. 2011;65:909–23 (quiz 24).PubMedCrossRef
281.
Gloviczki P, Hollier LH, Telander RL, Kaufman B, Bianco AJ, Stickler GB. Surgical implications of Klippel-Trenaunay syndrome. Ann Surg. 1983;197:353–62.PubMedPubMedCentralCrossRef
282.
McGrory BJ, Amadio PC. Klippel-Trenaunay syndrome: orthopaedic considerations. Orthop Rev. 1993;22:41–50.PubMed
283.
Takata M, Watanabe K, Matsubara H, Takato K, Nomura I, Tsuchiya H. Lengthening of the normal tibia in a patient with hemihypertrophy caused by Klippel-Trenaunay-Weber syndrome: a case report. J Orthop Surg (Hong Kong). 2011;19:359–63.CrossRef
284.
285.
Gates PE, Drvaric DM, Kruger L. Wound healing in orthopaedic procedures for Klippel-Trenaunay syndrome. J Pediatr Orthop. 1996;16:723–6.PubMedCrossRef
286.
Bajaj Y, Hewitt R, Ifeacho S, Hartley BE. Surgical excision as primary treatment modality for extensive cervicofacial lymphatic malformations in children. Int J Pediatr Otorhinolaryngol. 2011;75:673–7.PubMedCrossRef
287.
Orvidas LJ, Kasperbauer JL. Pediatric lymphangiomas of the head and neck. Ann Otol Rhinol Laryngol. 2000;109:411–21.PubMedCrossRef
288.
Alqahtani A, Nguyen LT, Flageole H, Shaw K, Laberge JM. 25 years’ experience with lymphangiomas in children. J Pediatr Surg. 1999;34:1164–8.CrossRefPubMed
289.
Wiegand S, Zimmermann AP, Eivazi B, Sesterhenn AM, Werner JA. Lymphatic malformations involving the parotid gland. Eur J Pediatr Surg. 2011;21:242–5.PubMedCrossRef
290.
Chen WL, Zhang B, Wang JG, Ye HS, Zhang DM, Huang ZQ. Surgical excision of cervicofacial giant macrocystic lymphatic malformations in infants and children. Int J Pediatr Otorhinolaryngol. 2009;73:833–7.PubMedCrossRef
291.
Lei ZM, Huang XX, Sun ZJ, Zhang WF, Zhao YF. Surgery of lymphatic malformations in oral and cervicofacial regions in children. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:338–44.PubMedCrossRef
292.
Okazaki T, Iwatani S, Yanai T, Kobayashi H, Kato Y, Marusasa T, et al. Treatment of lymphangioma in children: our experience of 128 cases. J Pediatr Surg. 2007;42:386–9.PubMedCrossRef
293.
Hamoir M, Plouin-Gaudon I, Rombaux P, Francois G, Cornu AS, Desuter G, et al. Lymphatic malformations of the head and neck: a retrospective review and a support for staging. Head Neck. 2001;23:326–37.PubMedCrossRef
294.
Fageeh N, Manoukian J, Tewfik T, Schloss M, Williams HB, Gaskin D. Management of head and neck lymphatic malformations in children. J Otolaryngol. 1997;26:253–8.PubMed
295.
Padwa BL, Hayward PG, Ferraro NF, Mulliken JB. Cervicofacial lymphatic malformation: clinical course, surgical intervention, and pathogenesis of skeletal hypertrophy. Plast Reconstr Surg. 1995;95:951–60.CrossRefPubMed
296.
de Serres LM, Sie KC, Richardson MA. Lymphatic malformations of the head and neck. A proposal for staging. Arch Otolaryngol Head Neck Surg. 1995;121:577–82.PubMedCrossRef
297.
Riechelmann H, Muehlfay G, Keck T, Mattfeldt T, Rettinger G. Total, subtotal, and partial surgical removal of cervicofacial lymphangiomas. Arch Otolaryngol Head Neck Surg. 1999;125:643–8.PubMedCrossRef
298.
Greinwald J Jr, Cohen AP, Hemanackah S, Azizkhan RG. Massive lymphatic malformations of the head, neck, and chest. J Otolaryngol Head Neck Surg. 2008;37:169–73.PubMed
299.
Yang Y, Sun M, Ma Q, Cheng X, Ao J, Tian L, et al. Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations. J Vasc Surg. 2011;53:150–5.PubMedCrossRef
300.
Alomari AI, Karian VE, Lord DJ, Padua HM, Burrows PE. Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement. J Vasc Interv Radiol. 2006;17:1639–48.PubMedCrossRef
301.
Chaudry G, Guevara CJ, Rialon KL, Kerr C, Mulliken JB, Greene AK, et al. Safety and efficacy of bleomycin sclerotherapy for microcystic lymphatic malformation. Cardiovasc Intervent Radiol. 2014;37:1476–81.PubMedCrossRef
302.
Smith MC, Zimmerman MB, Burke DK, Bauman NM, Sato Y, Smith RJ, et al. Efficacy and safety of OK-432 immunotherapy of lymphatic malformations. Laryngoscope. 2009;119:107–15.PubMedCrossRef
303.
Giguère CM, Bauman NM, Sato Y, Burke DK, Greinwald JH, Pransky S, et al. Treatment of lymphangiomas with OK-432 (Picibanil) sclerotherapy: a prospective multi-institutional trial. Arch Otolaryngol Head Neck Surg. 2002;128:1137–44.PubMedCrossRef
304.
Udagawa A, Yoshimoto S, Matumoto F, Ishii K, Nakajima Y, Hasegawa M, et al. A case of facial cavernous lymphangioma: observation from infancy to adulthood. Nihon Togai Gaku Ganmen Geka Gakkaishi. 2005;21:302–9.
305.
Nagao M, Sasaki S, Furukawa H, Uchiyama E, Yamamoto Y. Treatments for huge lymphatic malformations of cheek, oral cavity and neck. Nihon Keisei Geka Gakkai Kaishi. 2007;27:779–82 (Japanese).
306.
Ravindranathan H, Gillis J, Lord DJ. Intensive care experience with sclerotherapy for cervicofacial lymphatic malformations. Pediatr Crit Care Med. 2008;9:304–9.PubMedCrossRef
307.
Poonyathalang A, Preechawat P, Jiarakongmun P, Pongpech S. Sclerosing therapy for orbital lymphangioma using sodium tetradecyl sulfate. Jpn J Ophthalmol. 2008;52:298–304.PubMedCrossRef
308.
Emran MA, Dubois J, Laberge L, Al-Jazaeri A, Butter A, Yazbeck S. Alcoholic solution of zein (Ethibloc) sclerotherapy for treatment of lymphangiomas in children. J Pediatr Surg. 2006;41:975–9.PubMedCrossRef
309.
Bai Y, Jia J, Huang XX, Alsharif MJ, Zhao JH, Zhao YF. Sclerotherapy of microcystic lymphatic malformations in oral and facial regions. J Oral Maxillofac Surg. 2009;67:251–6.PubMedCrossRef
310.
Shiels WE 2nd, Kang DR, Murakami JW, Hogan MJ, Wiet GJ. Percutaneous treatment of lymphatic malformations. Otolaryngol Head Neck Surg. 2009;141:219–24.PubMedCrossRef
311.
Nehra D, Jacobson L, Barnes P, Mallory B, Albanese CT, Sylvester KG. Doxycycline sclerotherapy as primary treatment of head and neck lymphatic malformations in children. J Pediatr Surg. 2008;43:451–60.PubMedCrossRef
312.
Asonuma K, Inomata Y. Current strategy and outcome of treatment of lymphangioma in children: the analysis of a survey in the Kyushu and Okinawa area. Nihon Shoni Geka Gakkai Zasshi. 2006;42:215–21 (Japanese).
313.
Schwarcz RM, Ben Simon GJ, Cook T, Goldberg RA. Sclerosing therapy as first line treatment for low flow vascular lesions of the orbit. Am J Ophthalmol. 2006;141:333–9.PubMedCrossRef
314.
Oyama T, Eguchi K, Cho H, Abe H. A variety of orbital lymphangioma treatments: one case treated with orbital decompression therapy and the other case with intralesional injection of OK-432 therapy. Nihon Ganka Gakkai Zasshi. 2009;113:732–40 (Japanese).PubMed
315.
Cahill AM, Nijs E, Ballah D, Rabinowitz D, Thompson L, Rintoul N, et al. Percutaneous sclerotherapy in neonatal and infant head and neck lymphatic malformations: a single center experience. J Pediatr Surg. 2011;46:2083–95.PubMedCrossRef
316.
Chaudry G, Burrows PE, Padua HM, Dillon BJ, Fishman SJ, Alomari AI. Sclerotherapy of abdominal lymphatic malformations with doxycycline. J Vasc Interv Radiol. 2011;22:1431–5.PubMedCrossRef
317.
Oliveira C, Sacher P, Meuli M. Management of prenatally diagnosed abdominal lymphatic malformations. Eur J Pediatr Surg. 2010;20:302–6.PubMedCrossRef
318.
Won JH, Kim BM, Kim CH, Park SW, Kim MD. Percutaneous sclerotherapy of lymphangiomas with acetic acid. J Vasc Interv Radiol. 2004;15:595–600.PubMedCrossRef
319.
Shiels WE 2nd, Kenney BD, Caniano DA, Besner GE. Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities. J Pediatr Surg. 2008;43:136–9 (discussion 40).PubMedCrossRef
320.
Chiappinelli A, Forgues D, Galifer RB. Congenital abdominal cystic lymphangiomas: what is the correct management? J Matern Fetal Neonatal Med. 2012;25:915–9.PubMedCrossRef
321.
Muraoka A, Suzuki N, Niwa Y, Komatsu Y, Tagami K. A case report of an asymptomatic giant retroperitoneal lymphangioma pointed out at a physical examination. Nihon Rinsho Geka Gakkai Zasshi. 2009;70:899–905 (Japanese).CrossRef
322.
Oyachi N, Iwashita K, Kubo M. Diagnosis and management of mesenteric lymphangioma: comparison of prenatal and school-age diagnosed cases. Nihon Shoni Geka Gakkai Zasshi. 2008;44:33–7 (Japanese).
323.
Mendez-Gallart R, Bautista A, Estevez E, Rodriguez-Barca P. Abdominal cystic lymphangiomas in pediatrics: surgical approach and outcomes. Acta Chir Belg. 2011;111:374–7.PubMedCrossRef
324.
Ikeda T, Asai Y, Nango Y, Hoshino M, Ohashi K, Inoue M, et al. Childhood abdominal cystic lymphangioma. Nihon Shoni Geka Gakkai Zasshi. 2008;44:959–64 (Japanese).
325.
Losanoff JE, Kjossev KT. Mesenteric cystic lymphangioma: unusual cause of intra-abdominal catastrophe in an adult. Int J Clin Pract. 2005;59:986–7.PubMedCrossRef
326.
Uchiyama M, Murata H, Ohtaki M. Acute abdomen by inflammatory infiltration of retroperitoneal lymphangioma to the duodenum: report of a case and review of cases in childhood. Nihon Shoni Geka Gakkai Zasshi. 2007;43:938–44 (Japanese).
327.
Bellini C, Ergaz Z, Radicioni M, Forner-Cordero I, Witte M, Perotti G, et al. Congenital fetal and neonatal visceral chylous effusions: neonatal chylothorax and chylous ascites revisited. A multicenter retrospective study. Lymphology. 2012;45:91–102.PubMed
328.
Matsuo Y, Okada A. The role and use of Sudan Black in the surgical treatment of chylothorax and chylous ascites. Shoni Geka. 2001;33:186–90 (Japanese).
329.
Spagnol L, Conforti A, Valfre L, Morini F, Bagolan P. Preoperative administration of Sudan III and successful treatment of persistent chylous ascites in a neonate. J Pediatr Surg. 2011;46:994–7.PubMedCrossRef
330.
Joe K, Kemmotsu H, Mori T, Goto C, Ohkawa H. Treatment of idiopathic chylous ascites in infants. Shoni Geka. 2001;33:134–40 (Japanese).
331.
Moreira Dde A, Santos MM, Tannuri AC, Tannuri U. Congenital chylous ascites: a report of a case treated with hemostatic cellulose and fibrin glue. J Pediatr Surg. 2013;48:e17–9.PubMedCrossRef
332.
Olivieri C, Nanni L, Masini L, Pintus C. Successful management of congenital chylous ascites with early octreotide and total parenteral nutrition in a newborn. BMJ Case Rep. 2012;2012:bcr2012006196.PubMedPubMedCentralCrossRef
333.
Huang Y, Zhuang S, Li Y, Liu M, Chen H, Du M. Successful management of congenital chylous ascites in a premature infant using somatostatin analogue. Indian J Pediatr. 2011;78:345–7.PubMedCrossRef
334.
Melo-Filho AA, Souza IJ, Leite CA, Leite RD, Colares JH, Correia JM. Refractory congenital chylous ascites. Indian J Pediatr. 2010;77:1335–7.PubMedCrossRef
335.
Karagol BS, Zenciroglu A, Gokce S, Kundak AA, Ipek MS. Therapeutic management of neonatal chylous ascites: report of a case and review of the literature. Acta Paediatr. 2010;99:1307–10.PubMedCrossRef
336.
Kuroiwa M, Toki F, Suzuki M, Suzuki N. Successful laparoscopic ligation of the lymphatic trunk for refractory chylous ascites. J Pediatr Surg. 2007;42:E15–8.PubMedCrossRef
337.
Antao B, Croaker D, Squire R. Successful management of congenital chyloperitoneum with fibrin glue. J Pediatr Surg. 2003;38:E7–8.PubMedCrossRef
338.
Nakagawa J, Nakabayashi M, Kikuchi M, Sato C, Kido M, Kasai Y, et al. A case of congenital chyloperitoneum improved by prenatal treatment. Nihon Sanka Fujinka Gakkai Tokyo Chiho Bukai Kaishi. 2002;51:399–403 (Japanese).
339.
Wakisaka M, Kitagawa H, Satoh Y, Nakada K. Congenital chylo-ascites treated by laparotomy and OK-432 injection. Shoni Geka. 2001;33:196–200 (Japanese).
340.
Sato H, Okamatsu T, Yatsuzuka M, Gomi A, Suzuki J, Suzuki K, et al. Chylous ascites resolved by exploratory laparotomy. Shoni Geka. 2001;33:191–5 (Japanese).
341.
Takahashi A, Suzuki N, Kuwano H. Neonatal chylous ascites. Shoni Geka. 2001;33:144–7 (Japanese).
342.
Komuro H. Endoscopic surgery for chylothorax and chylous ascites. Shoni Geka. 2010;42:805–8 (Japanese).
343.
Zeidan S, Delarue A, Rome A, Roquelaure B. Fibrin glue application in the management of refractory chylous ascites in children. J Pediatr Gastroenterol Nutr. 2008;46:478–81.PubMedCrossRef
344.
Huang Q, Jiang ZW, Jiang J, Li N, Li JS. Chylous ascites: treated with total parenteral nutrition and somatostatin. World J Gastroenterol. 2004;10:2588–91.PubMedPubMedCentralCrossRef
345.
Nemoto T, Tsuchiya H, Nagashima K. Clinical and experimental analysis for chylothorax and chylous ascites. Shoni Geka. 2001;33:119–22 (Japanese).
346.
Ohtsu K, Ueda Y, Kurihara S, Kawashima M. Intractable chylous ascites. Shoni Geka. 2011;43:747–50 (Japanese).
347.
Ono S, Iwai N, Chiba F, Furukawa T, Fumino S. OK-432 therapy for chylous pleural effusion or ascites associated with lymphatic malformations. J Pediatr Surg. 2010;45:e7–10.PubMedCrossRef
348.
Tanaka M, Yokomori K, Kamii Y. Chylous ascites caused by a retroperitoneal lymphangioma: a case report. Shoni Geka. 2001;33:163–7 (Japanese).
349.
Siebert S, Helbling C, Wolff M, Franz A, Müller A, Kau N, et al. Peritoneovenous shunting as palliative treatment in an infant with chylous ascites due to generalised congenital lymphangiectasia. Klin Padiatr. 2010;222:317–8.PubMedCrossRef
350.
Densupsoontorn N, Jirapinyo P, Aanpreung P, Laohapensang M, Parichatikanond P. Congenital chylous ascites: the roles of fibrin glue and CD31. Acta Paediatr. 2009;98:1847–9.PubMedCrossRef
351.
Guvenc BH, Ekingen G, Tuzlaci A, Senel U. Diffuse neonatal abdominal lymphangiomatosis: management by limited surgical excision and sclerotherapy. Pediatr Surg Int. 2005;21:595–8.PubMedCrossRef
352.
Kotera A, Kamagata S, Hirobe S, Shimono R, Fuchimoto Y, Sakuma T, et al. A case of diffuse lymphangiomatosis with chylothorax and chylous ascites. Shoni Geka. 2001;33:128–33 (Japanese).
353.
Horisawa M, Nishimoto K, Ogura Y, Tainaka T, Matsunaga K, Niinomi N. Generalized lymphatic dysplasia with intermittent chylous discharge from the scrotum: a case report. Shoni Geka. 2001;33:180–5 (Japanese).
354.
Katz MS, Finck CM, Schwartz MZ, Moront ML, Prasad R, Timmapuri SJ, et al. Vacuum-assisted closure in the treatment of extensive lymphangiomas in children. J Pediatr Surg. 2012;47:367–70.PubMedCrossRef
355.
Sugito K, Ikeda T, Hagiwara N, Goto H, Endo K, Tanaka M, et al. A case of large mesenteric cyst with inflammatry reaction. Shoni Geka. 2001;33:1017–20 (Japanese).
356.
Chang TS, Ricketts R, Abramowsky CR, Cotter BD, Steelman CK, Husain A, et al. Mesenteric cystic masses: a series of 21 pediatric cases and review of the literature. Fetal Pediatr Pathol. 2011;30:40–4.PubMedCrossRef
357.
Tran NS, Nguyen TL. Laparoscopic management of abdominal lymphatic cyst in children. J Laparoendosc Adv Surg Tech A. 2012;22:505–7.PubMedCrossRef
358.
Boardman SJ, Cochrane LA, Roebuck D, Elliott MJ, Hartley BE. Multimodality treatment of pediatric lymphatic malformations of the head and neck using surgery and sclerotherapy. Arch Otolaryngol Head Neck Surg. 2010;136:270–6.PubMedCrossRef
359.
Park JG, Aubry MC, Godfrey JA, Midthun DE. Mediastinal lymphangioma: Mayo Clinic experience of 25 cases. Mayo Clin Proc. 2006;81:1197–203.PubMedCrossRef
360.
Adams MT, Saltzman B, Perkins JA. Head and neck lymphatic malformation treatment: a systematic review. Otolaryngol Head Neck Surg. 2012;147:627–39.PubMedCrossRef
361.
Leung M, Leung L, Fung D, Poon WL, Liu C, Chung K, et al. Management of the low-flow head and neck vascular malformations in children: the sclerotherapy protocol. Eur J Pediatr Surg. 2014;24:97–101.PubMedCrossRef
362.
Ogawa T, Shibayama M, Shimizu T. Clinical analysis of lymphangioma in the neck: the effects of local OK-432 injection therapy. Jibi Inkoka Rinsho. 2010;103:249–55 (Japanese).CrossRef
363.
Arimoto Y, Kudo F, Suzuki H. Usefulness of ultrasonography in the differential diagnosis of respiratory distress disorders including infantile paresis of the vocal cords. Shoni Jibi Inkoka. 2005;26:37–42 (Japanese).
364.
Kitagawa H, Kawase H, Wakisaka M, Satou Y, Satou H, Furuta S, et al. Six cases of children with a benign cervical tumor who required tracheostomy. Pediatr Surg Int. 2004;20:51–4.PubMedCrossRef
365.
Hiki S, Yamataka A, Kobayashi H, Okada Y, Miyano T. Treatment of lymphangioma in children. A report of 105 cases. Juntendo Igaku. 2003;48:476–83 (Japanese).CrossRef
366.
Desir A, Ghaye B, Duysinx B, Dondelinger RF. Percutaneous sclerotherapy of a giant mediastinal lymphangioma. Eur Respir J. 2008;32:804–6.PubMedCrossRef
367.
Kim DW. OK-432 sclerotherapy of lymphatic malformation in the head and neck: factors related to outcome. Pediatr Radiol. 2014;44:857–62.PubMedCrossRef
368.
Niramis R, Watanatittan S, Rattanasuwan T. Treatment of cystic hygroma by intralesional bleomycin injection: experience in 70 patients. Eur J Pediatr Surg. 2010;20:178–82.PubMedCrossRef
369.
Kudo F, Arimoto Y, Nakano A. Sclerosing therapy for cystic hygroma in infants: intracystic injection of OK-432. Tokeibu Geka. 2008;18:71–5 (Japanese).CrossRef
370.
Kim MG, Kim SG, Lee JH, Eun YG, Yeo SG. The therapeutic effect of OK-432 (picibanil) sclerotherapy for benign neck cysts. Laryngoscope. 2008;118:2177–81.PubMedCrossRef
371.
Baskota DK, Singh BB, Sinha BK. OK-432: an effective sclerosing agent for the treatment of lymphangiomas of head and neck. Kathmandu Univ Med J (KUMJ). 2007;5:312–7.
372.
Jamal N, Ahmed S, Miller T, Bent J, Brook A, Parikh S, et al. Doxycycline sclerotherapy for pediatric head and neck macrocystic lymphatic malformations: a case series and review of the literature. Int J Pediatr Otorhinolaryngol. 2012;76:1127–31.PubMedCrossRef
373.
Tomemori T, Kudo F, Sasamura Y, Numata T. Cystic hygroma in infants. Tokeibu Shuyo. 2003;29:58–63 (Japanese).
374.
Dasgupta R, Adams D, Elluru R, Wentzel MS, Azizkhan RG. Noninterventional treatment of selected head and neck lymphatic malformations. J Pediatr Surg. 2008;43:869–73.PubMedCrossRef
375.
Hogeling M, Adams S, Law J, Wargon O. Lymphatic malformations: clinical course and management in 64 cases. Australas J Dermatol. 2011;52:186–90.PubMedCrossRef
376.
Acevedo JL, Shah RK, Brietzke SE. Nonsurgical therapies for lymphangiomas: a systematic review. Otolaryngol Head Neck Surg. 2008;138:418–24.PubMedCrossRef
377.
Kim KH, Sung MW, Roh JL, Han MH. Sclerotherapy for congenital lesions in the head and neck. Otolaryngol Head Neck Surg. 2004;131:307–16.PubMedCrossRef
378.
Catalfamo L, Nava C, Lombardo G, Iudicello V, Siniscalchi EN, de Saverio PF. Tongue lymphangioma in adult. J Craniofac Surg. 2012;23:1920–2.PubMedCrossRef
379.
Magoshi S, Okada M, Shigematsu H, Suzuki S, Kusama K, Sakashita H. A case of hemangio-lymphangioma of the tongue. Nihon Koku Shindan Gakkai Zasshi. 2003;16:250–2 (Japanese).
380.
Ogiuchi H, Yamazaki T, Yamamura T, Kuwazawa T, Ogiuchi H. A long-term follow-up, case of lymphangioma of tongue and floor of the mouth. Shoni Koku Geka. 2003;13:17–20 (Japanese).
381.
Rowley H, Perez-Atayde AR, Burrows PE, Rahbar R. Management of a giant lymphatic malformation of the tongue. Arch Otolaryngol Head Neck Surg. 2002;128:190–4.PubMedCrossRef
382.
Chakravarti A, Bhargava R. Lymphangioma circumscriptum of the tongue in children: successful treatment using intralesional bleomycin. Int J Pediatr Otorhinolaryngol. 2013;77:1367–9.PubMedCrossRef
383.
Wiegand S, Eivazi B, Zimmermann AP, Neff A, Barth PJ, Sesterhenn AM, et al. Microcystic lymphatic malformations of the tongue: diagnosis, classification, and treatment. Arch Otolaryngol Head Neck Surg. 2009;135:976–83.PubMedCrossRef
384.
Hong JP, Lee MY, Kim EK, Seo DH. Giant lymphangioma of the tongue. J Craniofac Surg. 2009;20:252–4.PubMedCrossRef
385.
Azizkhan RG, Rutter MJ, Cotton RT, Lim LH, Cohen AP, Mason JL. Lymphatic malformations of the tongue base. J Pediatr Surg. 2006;41:1279–84.PubMedCrossRef
386.
Ogawa-Ochiai K, Sekiya N, Kasahara Y, Chino A, Ueda K, Kimata Y, et al. A case of mediastinal lymphangioma successfully treated with Kampo medicine. J Altern Complement Med. 2011;17:563–5.PubMedCrossRef
387.
Roy S, Reyes S, Smith LP. Bipolar radiofrequency plasma ablation (Coblation) of lymphatic malformations of the tongue. Int J Pediatr Otorhinolaryngol. 2009;73:289–93.PubMedCrossRef
388.
Kemmotsu T, Takeda Y, Nakamura K, Tateishi I. A case of congenital chylothorax requiring early OK-432 pleurodesis. Nihon Shusanki Shinseiji Igakkai Zasshi. 2012;48:945–50 (Japanese).
389.
Tani G, Okuyama H, Kubota A, Kawahara H. Thoracoscopic thoracic duct ligation in a premature infant with congenital chylothorax. Nihon Shoni Geka Gakkai Zasshi. 2011;47:844–7 (Japanese).
390.
Miura K, Yoshizawa K, Tamaki M, Okumura K, Okada M. Congenital chylothorax treated with video-assisted thoracic surgery. Kyobu Geka. 2008;61:1149–51 (Japanese).PubMed
391.
Amagai T, Nakamura H, Kaneko M, Sugiura M, Hamada H. Use and problems of pleuro-peritoneal shunting tube for neonatal chylothorax. Shoni Geka. 2001;33:201–7 (Japanese).
392.
Cleveland K, Zook D, Harvey K, Woods RK. Massive chylothorax in small babies. J Pediatr Surg. 2009;44:546–50.PubMedCrossRef
393.
Buttiker V, Fanconi S, Burger R. Chylothorax in children: guidelines for diagnosis and management. Chest. 1999;116:682–7.PubMedCrossRef
394.
Kaji M, Sakauchi M, Yoshii K, Seki A, Tani Y, Kishi T, et al. A case of chylothorax treated effectively with surgery. Tokyo Joshi Ika Daigaku Zasshi. 2013;83:E366–70 (Japanese).
395.
Haga T, Toida C, Muguruma T, Fujino A. Two cases of mediastinal lymphangiomatosis that required intensive care management. Nihon Shonika Gakkai Zasshi. 2013;117:1483–8 (Japanese).
396.
Chen YL, Lee CC, Yeh ML, Lee JS, Sung TC. Generalized lymphangiomatosis presenting as cardiomegaly. J Formos Med Assoc. 2007;106:S10–4.PubMedCrossRef
397.
Pfleger A, Schwinger W, Maier A, Tauss J, Popper HH, Zach MS. Gorham-Stout syndrome in a male adolescent-case report and review of the literature. J Pediatr Hematol Oncol. 2006;28:231–3.PubMedCrossRef
398.
Noda M, Endo C, Hoshikawa Y, Ishibashi N, Suzuki T, Okada Y, et al. Successful management of intractable chylothorax in Gorham-Stout disease by awake thoracoscopic surgery. Gen Thorac Cardiovasc Surg. 2013;61:356–8.PubMedCrossRef
399.
Fukahori S, Tsuru T, Asagiri K, Nakamizo H, Asakawa T, Tanaka H, et al. Thoracic lymphangiomatosis with massive chylothorax after a tumor biopsy and with disseminated intravenous coagulation–lymphoscintigraphy, an alternative minimally invasive imaging technique: report of a case. Surg Today. 2011;41:978–82.PubMedCrossRef
400.
Brodszki N, Lansberg JK, Dictor M, Gyllstedt E, Ewers SB, Larsson MK, et al. A novel treatment approach for paediatric Gorham-Stout syndrome with chylothorax. Acta Paediatr. 2011;100:1448–53.PubMedCrossRef
401.
Deveci M, Inan N, Corapcioglu F, Ekingen G. Gorham-Stout syndrome with chylothorax in a six-year-old boy. Indian J Pediatr. 2011;78:737–9.PubMedCrossRef
402.
Seok YK, Cho S, Lee E. Early surgical management of chylothorax complicated by Gorham’s disease. Thorac Cardiovasc Surg. 2010;58:492–3.PubMedCrossRef
403.
Kose M, Pekcan S, Dogru D, Akyuz C, Ozcelik U, Ozsurekci Y, et al. Gorham-Stout Syndrome with chylothorax: successful remission by interferon alpha-2b. Pediatr Pulmonol. 2009;44:613–5.PubMedCrossRef
404.
Boyle MJ, Alison P, Taylor G, Lightbourne BA. A case of Gorham’s disease complicated by bilateral chylothorax. Heart Lung Circ. 2008;17:64–6.PubMedCrossRef
405.
Burgess S, Harris M, Dakin C, Borzi P, Ryan C, Cooper D. Successful management of lymphangiomatosis and chylothorax in a 7-month-old infant. J Paediatr Child Health. 2006;42:560–2.PubMedCrossRef
406.
Underwood J, Buckley J, Manning B. Gorham disease: an intraoperative case study. AANA J. 2006;74:45–8.PubMed
407.
Fujiu K, Kanno R, Suzuki H, Nakamura N, Gotoh M. Chylothorax associated with massive osteolysis (Gorham’s syndrome). Ann Thorac Surg. 2002;73:1956–7.PubMedCrossRef
408.
Chavanis N, Chaffanjon P, Frey G, Vottero G, Brichon PY. Chylothorax complicating Gorham’s disease. Ann Thorac Surg. 2001;72:937–9.PubMedCrossRef
409.
Konez O, Vyas PK, Goyal M. Disseminated lymphangiomatosis presenting with massive chylothorax. Pediatr Radiol. 2000;30:35–7.PubMedCrossRef
410.
Morita K, Fukumoto K, Mitsunaga M, Yamoto M, Nouso H, Miyake H, et al. A case of thoracic lymphangiomatosis causing difficulty in treatment due to dyspnea and hemorrhage. Nihon Shoni Ketsueki Gan Gakkai Zasshi. 2013;50:644–9 (Japanese).
411.
Kitami A, Suzuki T, Suzuki S, Usuda R, Kamio Y, Kadokura M. Gorham’s disease complicated by chyloma of the chest wall. Jpn J Thorac Cardiovasc Surg. 2006;54:311–3.PubMedCrossRef
412.
Lee S, Finn L, Sze RW, Perkins JA, Sie KC. Gorham Stout syndrome (disappearing bone disease): two additional case reports and a review of the literature. Arch Otolaryngol Head Neck Surg. 2003;129:1340–3.PubMedCrossRef
413.
Reinglas J, Ramphal R, Bromwich M. The successful management of diffuse lymphangiomatosis using sirolimus: a case report. Laryngoscope. 2011;121:1851–4.PubMedCrossRef
414.
Tamay Z, Saribeyoglu E, Ones U, Anak S, Guler N, Bilgic B, et al. Diffuse thoracic lymphangiomatosis with disseminated intravascular coagulation in a child. J Pediatr Hematol Oncol. 2005;27:685–7.PubMedCrossRef
415.
Duffy BM, Manon R, Patel RR, Welsh JS. A case of Gorham’s disease with chylothorax treated curatively with radiation therapy. Clin Med Res. 2005;3:83–6.PubMedPubMedCentralCrossRef
416.
Kinnier CV, Eu JP, Davis RD, Howell DN, Sheets J, Palmer SM. Successful bilateral lung transplantation for lymphangiomatosis. Am J Transplant. 2008;8:1946–50.PubMedPubMedCentralCrossRef
417.
Huang SY, Lee YM, Tzeng ST, Su CP, Huang SF, Wu YK, et al. Gorham syndrome with postoperative respiratory failure and requiring prolonged mechanical ventilation. Respir Care. 2013;58:e144–8.PubMedCrossRef
418.
419.
Fontanesi J. Radiation therapy in the treatment of Gorham disease. J Pediatr Hematol Oncol. 2003;25:816–7.PubMedCrossRef
420.
421.
Timke C, Krause MF, Oppermann HC, Leuschner I, Claviez A. Interferon alpha 2b treatment in an eleven-year-old boy with disseminated lymphangiomatosis. Pediatr Blood Cancer. 2007;48:108–11.PubMedCrossRef
Metadata
Title
Japanese clinical practice guidelines for vascular anomalies 2017
Authors
Hidefumi Mimura
Sadanori Akita
Akihiro Fujino
Masatoshi Jinnin
Mine Ozaki
Keigo Osuga
Hiroki Nakaoka
Eiichi Morii
Akira Kuramochi
Yoko Aoki
Yasunori Arai
Noriko Aramaki
Masanori Inoue
Yuki Iwashina
Tadashi Iwanaka
Shigeru Ueno
Akihiro Umezawa
Michio Ozeki
Junko Ochi
Yoshiaki Kinoshita
Masakazu Kurita
Shien Seike
Nobuyuki Takakura
Masataka Takahashi
Takao Tachibana
Kumiko Chuman
Shuji Nagata
Mitsunaga Narushima
Yasunari Niimi
Shunsuke Nosaka
Taiki Nozaki
Kazuki Hashimoto
Ayato Hayashi
Satoshi Hirakawa
Atsuko Fujikawa
Yumiko Hori
Kentaro Matsuoka
Hideki Mori
Yuki Yamamoto
Shunsuke Yuzuriha
Naoaki Rikihisa
Shoji Watanabe
Shinichi Watanabe
Tatsuo Kuroda
Shunsuke Sugawara
Kosuke Ishikawa
Satoru Sasaki
Publication date
01-04-2020
Publisher
Springer Singapore
Published in
Japanese Journal of Radiology / Issue 4/2020
Print ISSN: 1867-1071
Electronic ISSN: 1867-108X
DOI
https://doi.org/10.1007/s11604-019-00885-5

Other articles of this Issue 4/2020

Japanese Journal of Radiology 4/2020 Go to the issue

Invited Review

PET and SPECT imaging of the brain: a review on the current status of nuclear medicine in Japan

Original Article

Usefulness of iodine-blood material density images in estimating degree of liver fibrosis by calculating extracellular volume fraction obtained from routine dual-energy liver CT protocol equilibrium phase data: preliminary experience

Original Article

Treatment of pulmonary arteriovenous malformations: clinical experience using different embolization strategies

Original Article

Diffusion-weighted imaging with simultaneous multi-slice echo-planar technique for the diagnosis of breast magnetic resonance imaging

Original Article

Dual-layer detector spectral CT versus magnetic resonance imaging for the assessment of iron overload in myelodysplastic syndromes and aplastic anemia